NVAX Q2 2017 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+168.7% YoY

Gross Profit

$7M100.0% margin

Operating Income

-$41M-616.0% margin

Net Income

-$44M-660.5% margin

EPS (Diluted)

$-3.14

QoQ Revenue Growth

+18.5%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$32M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$356M

Total Liabilities

$415M

Stockholders' Equity

-$59M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$3M	+168.7%
Gross Profit	$7M	$3M	+168.7%
Operating Income	-$41M	-$76M	+45.8%
Net Income	-$44M	-$79M	+44.0%